
|Articles|September 9, 2016
Resurgence of penicillin-susceptible isolates
Watch as Regis Kowalski, Executive Director, The Charles T. Campbell Laboratory at the University of Pittsburgh, explains how newly discovered resurgent isolates may affect clinical practice.
Advertisement
Watch as Regis Kowalski, Executive Director, The Charles T. Campbell Laboratory at the University of Pittsburgh, explains how newly discovered resurgent isolates may affect clinical practice.
Related articles:
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Tinlarebant NDA submission completed for Stargardt disease type 1, targeting first approved therapy
2
FDA accepts Outlook Therapeutics' resubmitted BLA for ONS-5010 (LYTENAVA)
3
Study finds mixed real and synthetic eye images enhance ocular AI performance
4
IOLs: What Every Surgeon Needs to Know | Ep. 2: Enhanced monofocal IOLs
5





















